Data gathered: June 1
AI Stock Analysis - Gilead Sciences (GILD)
Analysis generated March 11, 2025. Powered by Chat GPT.
Gilead Sciences, Inc. is an American biopharmaceutical company that focuses on the research, development, and commercialization of treatments for life-threatening diseases. Founded in 1987 and headquartered in Foster City, California, Gilead has grown into a prominent player in the biotechnology industry. The company’s portfolio includes treatments for HIV/AIDS, liver diseases, cancer, and inflammatory diseases. Gilead is known for its innovative approach to drug development, making it a key player in the healthcare sector.
Stock Alerts - Gilead Sciences (GILD)
 |
Gilead Sciences | May 24 Insider Alert: Mercier Johanna is selling shares |
|
Gilead Sciences | May 17 Insider Alert: Dickinson Andrew D is selling shares |
|
Gilead Sciences | May 12 Price is up by 7.1% in the last 24h. |
|
Gilead Sciences | May 7 Marjorie Taylor Greene (member of U.S. congress) is buying shares |
Download our app to get future alerts delivered in real-time.
Alternative Data for Gilead Sciences
About Gilead Sciences
Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases.
| Price | $110.08 |
| Target Price | Sign up |
| Volume | 11,910,000 |
| Market Cap | $138B |
| Year Range | $80.95 - $116.58 |
| Dividend Yield | 2.84% |
| PE Ratio | 23.37 |
| Analyst Rating | 62% buy |
| Industry | Biotechnology |
In the news
 |
Gilead Sciences Stock Gains 21% YTD: Buy, Sell or Hold?May 30 - Yahoo |
|
Gilead Sciences Commemorated the Opening of the Bay Area Young Survivors Breast Cancer Memorial GardenMay 29 - Yahoo |
 |
Gilead Sciences, Inc. (GILD) Bernstein 41st Annual Strategic Decisions Conference (Transcript)May 29 - SeekingAlpha |
Gilead Sciences Inc. stock outperforms competitors on strong trading dayMay 29 - MarketWatch |
|
Transcript : Gilead Sciences, Inc. Presents at Bernstein 41st Annual Strategic Decisions Conference 2025, May-29-2025 02May 29 - Finnhub |
|
|
Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending StockMay 28 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 6.67B | 961M | 5.71B | 1.32B | 1.91B | 1.810 |
| Q4 '24 | 7.57B | 1.58B | 5.99B | 1.78B | 3.11B | 1.900 |
| Q3 '24 | 7.55B | 1.57B | 5.97B | 1.25B | 1.88B | 2.020 |
| Q2 '24 | 6.95B | 1.54B | 5.41B | 1.61B | 2.98B | 2.010 |
| Q1 '24 | 6.69B | 1.55B | 5.13B | -4.17B | -3.54B | -1.320 |
Insider Transactions View All
| Mercier Johanna filed to sell 121,152 shares at $107.5. May 23 '25 |
| Mercier Johanna filed to sell 124,152 shares at $107.5. May 23 '25 |
| Dickinson Andrew D filed to sell 165,674 shares at $99.8. May 16 '25 |
| Dickinson Andrew D filed to sell 168,174 shares at $106.4. April 16 '25 |
| Dickinson Andrew D filed to sell 170,674 shares at $110.5. March 18 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Marjorie Taylor Greene |
May 7, 25 | Buy | $1K - $15K |
| Jefferson Shreve |
Apr 14, 25 | Buy | $15K - $50K |
| Carol Devine Miller |
Apr 11, 25 | Buy | $1K - $15K |
Read more about Gilead Sciences (GILD) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Gilead Sciences?
The Market Cap of Gilead Sciences is $138B.
What is Gilead Sciences' PE Ratio?
As of today, Gilead Sciences' PE (Price to Earnings) ratio is 23.37.
What is the current stock price of Gilead Sciences?
Currently, the price of one share of Gilead Sciences stock is $110.08.
How can I analyze the GILD stock price chart for investment decisions?
The GILD stock price chart above provides a comprehensive visual representation of Gilead Sciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Gilead Sciences shares. Our platform offers an up-to-date GILD stock price chart, along with technical data analysis and alternative data insights.
Does GILD offer dividends to its shareholders?
Yes, Gilead Sciences (GILD) offers dividends to its shareholders, with a dividend yield of 2.84%. This dividend yield represents Gilead Sciences' commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Gilead Sciences in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Gilead Sciences?
Some of the similar stocks of Gilead Sciences are Amgen, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Anavex Life Sciences, and BridgeBio Pharma.
.